Gentian Diagnostics ASA

Report Publication Announcement • May 9, 2017

Q1 2017 Financial Report

Q1 2017 Financial Report

Moss, 9 May 2017

Gentian Diagnostics AS announces its results for the first quarter.

The highlights of the quarter include:

- Plasma calprotectin test on track to be launched in the

second half of 2017

- Continued progress in all development projects

- Proof-of-Concept achieved for G-1001 and the Nanosense II

technology

- Successful completion of MNOK 100 equity raise

- Swedish subsidiary Gentian Diagnostics AB opened in March

Please find the report for the first quarter enclosed. The

report will also be made available on www.gentian.no.

For further information, please contact:

Bård Sundrehagen

CEO, Gentian Diagnostics

E-mail: Bard.sundrehagen@gentian.no

Cell Phone: +47 924 14 117